Insider Monitor  
 



Insider Trading: Genomic Health Inc

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Genomic Health Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Genomic Health Inc since year 2005. Table 2 shows the detailed insider transactions of Genomic Health Inc since 2005. The reporting company's ticker symbol is GHDX. The reporting company's CIK number is 1131324.

The total value of stock buying since 2005 is $402,130,668. The total value of stock sales is $49,674,467. The total value of stock exercises is $3,543,113.
1 year stock price chart,   1 day stock price chart
GHDX 1 year chart
GHDX 1 day chart

Figure 1. Monthly insider transaction values at Genomic Health Inc (GHDX) in the past 24 months. The trade values of insider stock buys, sales, and option exercises are in logarithmic scale as shown on the right axis labels. The detailed monthly and daily insider transactions are listed in the 2 tables below.

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2012

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2013

  • 02

  • 03

  • 04

  • 05

  • $52,044k

    $5,204k

    $520k

    $52k

  • Buy
  • Sale
  • Option Exercise

Figure 2. Average prices of insider buys, sales, and option exercises at Genomic Health Inc (GHDX) in the past 24 months. See table 2 for insider transaction details.

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2012

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2013

  • 02

  • 03

  • 04

  • 05

  • $35.72

    $26.79

    $17.86

    $8.93



Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Genomic Health Inc (GHDX).
Trading Period
year-month  
Insider Buying     
Shares               Value ($)
Insider Sales     
Shares               Value ($)
Option Exercises     
Shares               Value ($)
2013-05 311,865 10,901,379 14,087 498,492 14,087 114,556
2013-04 0 0 5,000 144,482 5,000 10,525
2013-03 0 0 2,500 71,435 2,500 3,325
2013-02 217,445 6,119,759 46,466 1,318,016 43,750 781,960
2013-01 0 0 7,125 200,739 7,125 30,627
2012-12 0 0 15,500 431,107 5,500 31,495
2012-11 1,156,239 31,525,505 48,116 1,306,607 7,500 34,149
2012-10 0 0 21,750 736,466 11,750 174,382
2012-09 0 0 12,500 414,765 2,500 3,325
2012-08 0 0 34,000 1,180,157 32,250 372,570
2012-07 0 0 46,600 1,652,117 6,600 54,930
2012-06 0 0 42,500 1,429,860 2,500 3,325
2012-05 854,973 26,965,075 74,794 2,398,312 7,500 119,875
2012-04 0 0 35,500 1,013,613 4,500 5,979
2012-03 428,145 12,789,188 63,500 1,939,635 2,500 3,325
2012-02 1,846,592 52,044,225 38,255 1,037,135 2,500 3,325
2012-01 0 0 40,500 1,103,159 4,500 5,979
2011-12 304,071 8,528,204 27,500 753,560 2,500 3,325
2011-11 1,415,609 37,478,369 27,500 741,665 7,500 50,275
2011-10 0 0 32,000 721,125 12,000 56,254
2011-09 0 0 27,500 569,710 7,500 50,275
2011-08 0 0 27,500 666,981 7,500 50,275
2011-07 0 0 32,000 876,856 12,000 56,254
2011-06 491,170 12,969,827 28,500 740,781 7,500 50,275
2011-05 116,208 3,167,096 28,500 752,196 7,500 50,275
2011-04 0 0 41,000 1,061,996 15,000 124,724
2011-03 1,019,260 25,953,993 70,820 1,789,399 13,000 122,070
2011-02 85,476 2,144,763 34,000 762,991 18,000 183,495
2011-01 0 0 34,276 741,307 14,276 33,364
2010-12 0 0 30,500 687,520 10,500 26,365
2010-11 0 0 30,500 550,440 60,500 542,865
2010-10 0 0 20,000 279,000 0 0
2010-09 51,342 745,705 30,234 451,764 10,234 25,598
2010-08 864,973 12,611,379 35,129 520,597 10,500 26,365
2010-07 0 0 24,629 316,583 0 0
2010-06 0 0 24,629 347,952 0 0
2010-05 0 0 35,129 550,000 10,500 26,365
2010-04 0 0 29,629 500,051 5,000 6,650
2010-03 0 0 153,829 2,990,247 2,500 3,325
2010-02 500,088 8,496,802 27,129 467,639 2,500 3,325
2010-01 0 0 9,629 167,114 5,000 6,650
2009-12 0 0 28,629 580,159 0 0
2009-11 0 0 37,294 730,015 665 884
2009-10 0 0 26,629 551,250 0 0
2009-09 0 0 26,629 550,538 0 0
2009-08 360,972 7,116,249 31,629 624,684 5,000 6,650
2009-07 0 0 4,629 74,114 0 0
2009-06 0 0 10,629 191,497 0 0
2009-05 321,783 6,216,101 26,629 520,450 0 0
2009-04 0 0 16,629 425,350 0 0
2009-03 0 0 16,629 321,343 0 0
2009-02 0 0 21,629 455,022 5,000 6,650
2009-01 0 0 4,629 89,858 0 0
2008-12 0 0 16,729 311,955 69,348 219,833
2008-11 0 0 26,629 535,565 10,000 13,300
2008-10 0 0 25,887 553,977 0 0
2008-09 0 0 30,887 691,589 0 0
2008-08 0 0 55,927 1,330,867 5,000 6,650
2008-07 0 0 16,629 341,136 0 0
2008-06 493,611 9,796,688 16,729 324,292 0 0
2008-05 0 0 16,629 314,159 0 0
2008-04 0 0 12,000 206,658 0 0
2008-03 0 0 16,629 320,821 0 0
2008-02 0 0 30,629 686,732 10,201 9,645
2008-01 0 0 16,629 411,393 0 0
2007-12 0 0 4,629 106,906 0 0
2007-11 0 0 11,284 253,849 0 0
2007-10 0 0 16,629 333,777 0 0
2007-09 0 0 40,629 799,617 0 0
2007-08 5,350 100,387 16,629 328,861 0 0
2007-07 0 0 16,629 342,235 0 0
2007-06 0 0 16,629 311,131 0 0
2007-05 4,000,143 64,065,260 16,629 274,912 0 0
2007-04 0 0 16,629 286,649 43,345 27,480
2007-03 628,786 11,484,376 16,629 304,353 0 0
2007-02 811,781 14,845,020 16,629 305,182 0 0
2006-12 953,338 19,285,985 0 0 0 0
2006-09 1,195,954 16,779,333 0 0 0 0

Table 2. Detailed insider stock purchases, sales, and option exercises for Genomic Health Inc (GHDX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-05-16 Baker Bros Advisors Llc (Director) Purchase 19,306 36.54 705,421
2013-05-15 Baker Bros Advisors Llc (Director) Purchase 52,133 36.41 1,898,371
2013-05-15 Livingston Randall S (Director) Sale 1,337 35.83 47,903
2013-05-15 Livingston Randall S (Director) Option Exercise 1,337 1.33 1,774
2013-05-14 Baker Bros Advisors Llc (Director) Purchase 27,184 35.53 965,901
2013-05-13 Popovits Kimberly J (President and CEO) Sale 5,000 34.70 173,505
2013-05-13 Popovits Kimberly J (President and CEO) Option Exercise 5,000 2.88 14,400
2013-05-13 Hibbs Kathy L (SVP & General Counsel) Sale 1,250 34.42 43,031
2013-05-13 Hibbs Kathy L (SVP & General Counsel) Option Exercise 1,250 21.07 26,337
2013-05-13 Baker Bros Advisors Llc (Director) Purchase 213,242 34.38 7,331,686
2013-05-09 Schorno Dean L (CFO) Sale 4,000 36.02 144,088
2013-05-09 Schorno Dean L (CFO) Option Exercise 4,000 17.18 68,720
2013-05-08 Cole G Bradley (COO) Sale 2,500 35.99 89,965
2013-05-08 Cole G Bradley (COO) Option Exercise 2,500 1.33 3,325
2013-04-23 Popovits Kimberly J (President and CEO) Sale 2,500 30.00 75,000
2013-04-23 Popovits Kimberly J (President and CEO) Option Exercise 2,500 2.88 7,200
2013-04-03 Cole G Bradley (COO) Sale 2,500 27.79 69,482
2013-04-03 Cole G Bradley (COO) Option Exercise 2,500 1.33 3,325
2013-03-06 Cole G Bradley (COO) Sale 2,500 28.57 71,435
2013-03-06 Cole G Bradley (COO) Option Exercise 2,500 1.33 3,325
2013-02-21 Baker Bros Advisors Llc (Director) Purchase 28,200 27.64 779,335
2013-02-20 Hibbs Kathy L (SVP & General Counsel) Sale 2,716 28.13 76,398
2013-02-20 Baker Bros Advisors Llc (Director) Purchase 20,885 27.97 584,216
2013-02-14 Baker Bros Advisors Llc (Director) Purchase 34,800 28.43 989,398
2013-02-14 Myers Woodrow A Jr (Director) Sale 41,250 28.40 1,171,541
2013-02-14 Myers Woodrow A Jr (Director) Option Exercise 41,250 18.88 778,635
2013-02-13 Baker Bros Advisors Llc (Director) Purchase 17,200 28.58 491,593
2013-02-11 Baker Bros Advisors Llc (Director) Purchase 79,984 28.23 2,258,108
2013-02-08 Baker Bros Advisors Llc (Director) Purchase 36,376 27.96 1,017,109
2013-02-06 Cole G Bradley (COO) Sale 2,500 28.03 70,077
2013-02-06 Cole G Bradley (COO) Option Exercise 2,500 1.33 3,325
2013-01-28 Livingston Randall S (Director) Sale 2,000 28.77 57,544
2013-01-28 Livingston Randall S (Director) Option Exercise 2,000 1.33 2,654
2013-01-09 Schorno Dean L (CFO) Sale 2,625 28.00 73,500
2013-01-09 Schorno Dean L (CFO) Option Exercise 2,625 9.39 24,648
2013-01-09 Cole G Bradley (COO) Sale 2,500 27.88 69,695
2013-01-09 Cole G Bradley (COO) Option Exercise 2,500 1.33 3,325
2012-12-18 Shak Steven (EVP of R&D & CMO) Sale 5,000 27.74 138,720
2012-12-13 Popovits Kimberly J (President and CEO) Sale 5,000 28.09 140,440
2012-12-11 Schorno Dean L (CFO) Sale 3,000 28.00 84,000
2012-12-11 Schorno Dean L (CFO) Option Exercise 3,000 9.39 28,170
2012-12-06 Cole G Bradley (COO) Sale 2,500 27.18 67,947
2012-12-06 Cole G Bradley (COO) Option Exercise 2,500 1.33 3,325
2012-11-26 Livingston Randall S (Director) Sale 2,000 27.84 55,684
2012-11-26 Livingston Randall S (Director) Option Exercise 2,000 1.33 2,654
2012-11-21 Baker Bros Advisors Llc (Director) Purchase 300 27.54 8,262
2012-11-20 Shak Steven (EVP of R&D & CMO) Sale 5,000 27.17 135,845
2012-11-20 Baker Bros Advisors Llc (Director) Purchase 229,000 26.83 6,143,383
2012-11-20 Colella Samuel D (Director) Sale 5,500 26.52 145,843
2012-11-19 Colella Samuel D (Director) Sale 25,116 26.97 677,478
2012-11-14 667, L.p. (Director) Purchase 103,167 27.32 2,818,212
2012-11-14 Popovits Kimberly J (President and CEO) Sale 5,000 27.24 136,215
2012-11-13 667, L.p. (Director) Purchase 103,839 27.99 2,906,661
2012-11-12 667, L.p. (Director) Purchase 200,000 27.94 5,587,400
2012-11-12 Schorno Dean L (CFO) Sale 2,800 28.00 78,400
2012-11-12 Schorno Dean L (CFO) Option Exercise 2,800 9.39 26,292
2012-11-09 667, L.p. (Director) Purchase 519,933 27.04 14,061,587
2012-11-09 Schorno Dean L (CFO) Sale 200 28.00 5,600
2012-11-09 Schorno Dean L (CFO) Option Exercise 200 9.39 1,878
2012-11-08 Cole G Bradley (COO) Sale 2,500 28.62 71,542
2012-11-08 Cole G Bradley (COO) Option Exercise 2,500 1.33 3,325
2012-10-16 Shak Steven (EVP of R&D & CMO) Sale 5,000 35.01 175,055
2012-10-16 Popovits Kimberly J (President and CEO) Sale 5,000 35.00 175,000
2012-10-16 Popovits Kimberly J (President and CEO) Option Exercise 5,000 23.31 116,550
2012-10-15 Popovits Kimberly J (President and CEO) Sale 5,000 31.17 155,840
2012-10-12 Schorno Dean L (CFO) Sale 3,000 33.79 101,358
2012-10-12 Schorno Dean L (CFO) Option Exercise 3,000 9.39 28,170
2012-10-11 Hibbs Kathy L (SVP & General Counsel) Sale 1,250 33.78 42,223
2012-10-11 Hibbs Kathy L (SVP & General Counsel) Option Exercise 1,250 21.07 26,337
2012-10-09 Cole G Bradley (COO) Sale 2,500 34.80 86,990
2012-10-09 Cole G Bradley (COO) Option Exercise 2,500 1.33 3,325
2012-09-18 Shak Steven (EVP of R&D & CMO) Sale 5,000 33.76 168,800
2012-09-13 Popovits Kimberly J (President and CEO) Sale 5,000 31.69 158,450
2012-09-06 Cole G Bradley (COO) Sale 2,500 35.01 87,515
2012-09-06 Cole G Bradley (COO) Option Exercise 2,500 1.33 3,325
2012-08-21 Myers Woodrow A Jr (Director) Sale 10,993 35.28 387,800
2012-08-21 Myers Woodrow A Jr (Director) Option Exercise 10,993 9.95 109,380
2012-08-20 Shak Steven (EVP of R&D & CMO) Sale 5,000 34.99 174,940
2012-08-20 Myers Woodrow A Jr (Director) Sale 5,507 35.06 193,058
2012-08-20 Myers Woodrow A Jr (Director) Option Exercise 5,507 9.95 54,794
2012-08-14 Popovits Kimberly J (President and CEO) Sale 3,103 35.07 108,812
2012-08-14 Popovits Kimberly J (President and CEO) Option Exercise 3,103 23.31 72,330
2012-08-13 Popovits Kimberly J (President and CEO) Sale 6,897 34.70 239,312
2012-08-13 Popovits Kimberly J (President and CEO) Option Exercise 1,897 23.31 44,219
2012-08-08 Cole G Bradley (COO) Sale 2,500 30.49 76,235
2012-08-08 Cole G Bradley (COO) Option Exercise 2,500 1.33 3,325
2012-08-01 Cohen Fred E (Director) Option Exercise 8,250 10.73 88,522
2012-07-26 Livingston Randall S (Director) Sale 2,000 35.90 71,800
2012-07-26 Livingston Randall S (Director) Option Exercise 2,000 1.33 2,654
2012-07-24 Shak Steven (Chief Medical Officer) Sale 5,000 34.24 171,195
2012-07-13 Popovits Kimberly J (President and CEO) Sale 7,100 34.84 247,342
2012-07-13 Popovits Kimberly J (President and CEO) Option Exercise 2,100 23.31 48,951
2012-07-11 Scott Randal W (CEO, InVitae Corporation*) Sale 15,000 35.16 527,340
2012-07-10 Scott Randal W (CEO, InVitae Corporation*) Sale 15,000 36.30 544,575
2012-07-05 Cole G Bradley (COO) Sale 2,500 35.95 89,865
2012-07-05 Cole G Bradley (COO) Option Exercise 2,500 1.33 3,325
2012-06-25 Shak Steven (Chief Medical Officer) Sale 5,000 33.25 166,250
2012-06-13 Popovits Kimberly J (President and CEO) Sale 5,000 33.36 166,805
2012-06-12 Scott Randal W (CEO, InVitae Corporation*) Sale 15,000 33.31 499,650
2012-06-11 Scott Randal W (CEO, InVitae Corporation*) Sale 15,000 34.15 512,235
2012-06-06 Cole G Bradley (COO) Sale 2,500 33.97 84,920
2012-06-06 Cole G Bradley (COO) Option Exercise 2,500 1.33 3,325
2012-05-31 Popovits Kimberly J (President and CEO) Purchase 919 23.11 21,239
2012-05-24 Shak Steven (Chief Medical Officer) Sale 5,000 33.80 168,980
2012-05-22 Baker Felix (Director) Purchase 17,406 32.94 573,405
2012-05-21 Baker Felix (Director) Purchase 150,000 32.12 4,818,450
2012-05-18 Colella Samuel D (Director) Sale 9,300 32.13 298,790
2012-05-17 Colella Samuel D (Director) Sale 16,994 33.52 569,689
2012-05-16 Popovits Kimberly J (President and CEO) Sale 5,000 35.00 175,000
2012-05-16 Popovits Kimberly J (President and CEO) Option Exercise 5,000 23.31 116,550
2012-05-16 Baker Felix (Director) Purchase 23,621 34.46 813,932
2012-05-15 Schorno Dean L (CFO) Sale 1,000 33.69 33,686
2012-05-15 Popovits Kimberly J (President and CEO) Sale 5,000 33.46 167,290
2012-05-15 Baker Felix (Director) Purchase 140,000 33.94 4,752,160
2012-05-14 Baker Felix (Director) Purchase 212,438 32.92 6,994,521
2012-05-11 Scott Randal W (CEO, InVitae Corporation*) Sale 15,000 30.74 461,145
2012-05-11 Baker Felix (Director) Purchase 26,660 30.22 805,558
2012-05-10 Scott Randal W (CEO, InVitae Corporation*) Sale 15,000 30.10 451,560
2012-05-10 Baker Felix (Director) Purchase 68,681 29.92 2,054,798
2012-05-09 Cole G Bradley (COO) Sale 2,500 28.87 72,172
2012-05-09 Cole G Bradley (COO) Option Exercise 2,500 1.33 3,325
2012-05-09 Baker Felix (Director) Purchase 19,547 29.90 584,357
2012-05-08 Baker Felix (Director) Purchase 86,033 28.60 2,460,543
2012-05-07 Baker Felix (Director) Purchase 56,540 28.26 1,598,103
2012-05-04 Baker Felix (Director) Purchase 53,128 28.01 1,488,009
2012-04-26 Livingston Randall S (Director) Sale 2,000 28.21 56,428
2012-04-26 Livingston Randall S (Director) Option Exercise 2,000 1.33 2,654
2012-04-24 Shak Steven (Chief Medical Officer) Sale 5,000 27.93 139,630
2012-04-23 Popovits Kimberly J (President and CEO) Sale 5,000 27.79 138,965
2012-04-16 Schorno Dean L (CFO) Sale 1,000 27.98 27,980
2012-04-11 Scott Randal W (CEO, InVitae Corporation*) Sale 10,000 28.38 283,790
2012-04-10 Scott Randal W (CEO, InVitae Corporation*) Sale 10,000 29.11 291,130
2012-04-04 Cole G Bradley (COO) Sale 2,500 30.28 75,690
2012-04-04 Cole G Bradley (COO) Option Exercise 2,500 1.33 3,325
2012-03-22 Shak Steven (Chief Medical Officer) Sale 10,000 30.08 300,830
2012-03-22 Popovits Kimberly J (President and CEO) Sale 10,000 30.07 300,670
2012-03-15 Schorno Dean L (CFO) Sale 1,000 31.08 31,080
2012-03-13 Scott Randal W (CEO, InVitae Corporation) Sale 15,000 31.12 466,770
2012-03-12 Scott Randal W (CEO, InVitae Corporation) Sale 15,000 30.98 464,685
2012-03-08 Cole G Bradley (COO) Sale 2,500 29.94 74,850
2012-03-08 Cole G Bradley (COO) Option Exercise 2,500 1.33 3,325
2012-03-08 Baker Felix (Director) Purchase 22,191 30.36 673,805
2012-03-07 Baker Felix (Director) Purchase 25,000 29.88 746,974
2012-03-05 Baker Felix (Director) Purchase 177,710 30.01 5,333,432
2012-03-02 Baker Felix (Director) Purchase 104,850 29.52 3,095,170
2012-03-01 Baker Felix (Director) Purchase 17,456 29.47 514,427
2012-02-29 Baker Felix (Director) Purchase 180,603 29.06 5,247,961
2012-02-28 Baker Felix (Director) Purchase 58,535 29.11 1,703,835
2012-02-27 Baker Felix (Director) Purchase 42,125 29.03 1,222,930
2012-02-24 Popovits Kimberly J (President and CEO) Sale 5,000 28.85 144,255

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Genomic Health Inc (symbol GHDX, CIK number 1131324) see the Securities and Exchange Commission (SEC) website.



©2013, insider-monitor.com. All rights reserved.